Oncology
 |
|
30 march 2017 08:33:44 |
| Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical development (Oncogene) |
|
Tweet |
| 107 viewsCategory: Oncology |
 [Editorial] Preventable cancer: off-limits for Commonwealth meeting? (Lancet Oncology)Translational research in neuroendocrine tumors: pitfalls and opportunities (Oncogene) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
